Scientific and Medical Equipment House Co. (Equipment House) reported a net profit (excluding minority interest) of SAR 7.8 million in Q1 2025, down 11% compared to SAR 8.8 million in Q1 2024.
Item | Q1 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 216.18 | 221.73 | 2.6 % |
Gross Income | 37.36 | 33.27 | (11.0 %) |
Operating Income | 17.10 | 13.77 | (19.5 %) |
Net Income | 8.77 | 7.69 | (12.3 %) |
Average Shares | 30.00 | 30.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.29 | 0.26 | (12.3 %) |
EPS (Riyal) | 0.29 | 0.26 | (12.3 %) |
Item | Q4 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 227.23 | 221.73 | (2.4 %) |
Gross Income | 26.51 | 33.27 | 25.5 % |
Operating Income | 5.54 | 13.77 | 148.6 % |
Net Income | (1.17) | 7.69 | 757.0 % |
Average Shares | 30.00 | 30.00 | - |
Earnings Per Share before unusual items (Riyal) | (0.04) | 0.26 | 757.0 % |
EPS (Riyal) | (0.04) | 0.26 | 757.0 % |
Lower earnings were due to higher operating expenses, including salaries, wages, and the cost of labour. This was offset by an increase of 2.5% year-on-year (YoY) in revenue as the company started seven new projects in subdivisions (non-medical operations, catering and supplies, and medical maintenance).
Net profit, before minority interest, reached SAR 7.3 million in Q1 2025, compared to SAR 8.3 million a year earlier.
On a sequential basis, the company swung to a profit versus a net loss of SAR 1.17 million in Q4 2024.
Total shareholders’ equity, after minority interest, stood at SAR 512.3 million as of March 31, 2025, compared to SAR 515.1 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: